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OBJECTIVES OF THE THESIS 
During the 15 years in which plasmapheresis has been 
performed in the Department of Haematology at the University 
of Cape Town and Groote Schuur Hospital I have been 
responsible for the procedures as a result of which a number 
of abnormalities have been investigated and reported. The 
problems include disturbances of haemostasis, 1 a.luminium or 
calcium homeostasis 213 and benefits in haematologic 
emergencies were documented. 415 A particular and long-standing 
interest has been in the control of plasma cholesterol levels 
using exchange procedures and it was in these patients that 
anaemia was constantly observed. Despite a literature search 
and discussions at haemapheresis meetings this association 
seems not to have been studied. 
The sub-normal haemoglobin concentrations were shown to 
result from absolute iron deficiency and this could not be 
accounted for solely on a dietary basis but rather from 
additional blood loss. One source was iatrogenic and took the 
form of frequent specimen collections. Another was 
intravascular haemolysis that may complicate cell separation. 6 
Thus it was postulated that erythrocytes, in these individuals 
with sub-optimal stores and hypercholesterolaemia, might be 
unduly susceptible to shear stresses during circulation. This, 
in itself, would then reduce their life-span and potentially 
be aggravated by turbulence generated at either site of a 
surgically created arteriovenous shunt or passage through the 
1 
extra-corporeal pathway. When repeated over many years, such 
low-level breakdown with urinary loss would deplete stores. 
STUDY DESIGN 
To test this hypothesis a research protocol was approved 
by the University and Hospital Ethics and Research Committees 
with participation requiring informed consent. 
Firstly, haemoglobin, red cell indices, plasma ferritin 
and percentage saturation of transferrin were measured to 
document iron stores. Dietary availability of iron was 
estimated both quantitatively and qualitatively using a 
questionnaire. Secondly losses occurring with the 
plasmaphereses and in urine was accurately measured by 
inductively coupled plasma-atomic emission spectroscopy (ICP-
AES): note was particularly taken of additional iron depletion 
due to blood sampling. Serum lactic dehydrogenase and free 
plasma haemoglobin levels were used to screen for haemolysis. 
Concurrent compensation in red cell production was defined by 
alterations in erythropoietin concentration, shift in the 
reticulocyte maturation index, glucose-6-phosphate 
dehydrogenase and pyruvate kinase levels. 
Erythrocyte survival was determined 
standard radioisotope techniques. 
directly with 
The possibility exists that erythrocytes in these 
patients may be intrinsically less deformable and therefore 
more fragile than usual. This would cause increased 
susceptibility to destruction even prior to treatment with 
exaggeration during therapeutic plasmapheresis. To this end 
ektacytometry was used to characterise deformability and 
fragility in the homozygotes as well as normal individuals. 
2 
The central issue was early appreciated as being that of 
iron deficiency anaemia. Accordingly this was the focus of the 
methods employed and results reported. Nevertheless, in the 
interests of completeness and because negative iron balance is 
known to influence haematopoietic parameters such as 
thrombocytopoiesis, additional observations were made to 
characterise such associations. These are separated from the 
main thrust of the study in supplementary chapters for 
relevant methodology and results. 
The data were collated and statistically examined, using 
appropriate techniques, to see whether the presence of a 
membrane lesion was primarily attributable to iron loss or 
possibly with a contribution from hypercholesterolaemia. 
Irrespective of the causation such a situation might favour 
acceleration in the physiologic process of extravascular 
destruction with the additional mechanical trauma of the 
exchange leading to cellular breakdown in the circulation with 




The relevance of this investigation is two fold. Firstly, 
is the description of a previously unrecognised 
haematologic lesion in these patients. Secondly, application 
of this information has direct clinical applicability. 
Pathological increases in plasma cholesterol levels 
together with a variety of inherited abnormalities occur 
commonly in the Afrikaner population of sub-Saharan Africa and 
t his is explicable on the founder effect. 7 - 9 In homozygotes 
standard therapeutic options have limited benefit so that 
3 
plasmapheresis has become established as a standard procedure 
for lipid control.lO,ll It is in this context that the anaemia 
was first noticed and the hypochromic and microcytic nature 
correlated with depleted body iron stores. Since the latter 
state gives rise to symptoms, may further shorten red cell 
survival and can itself result in paradoxical hyperviscosity 
there is good reason to prevent its development by oral iron 
supplementation. Such an intervention can be anticipated to 
improve quality of life in patients whose survival is 
critically dependant on long-term plasma exchange. 
4 
INCIDENCE OF ANAEMIA 
CHAPTER II 
ABSTRACT 
Many patients undergo single or brief but intensive 
plasmapheresis and here a number of abnormalities have been 
recorded including altered concentrations in trace metals and 
coagulation proteins but anaemia is not a feature. In contrast 
those on long-term exchange protocols, as for familial 
homozygous hypercholesterolaemia ( FH) , were found 'in a cohort 
of six to universally drop their haemoglobin levels. 
CHARACTERISATION 
Hypochromic and microcytic erythrocytes, together with 
sub-normal ferritin levels and percentage saturation of 
transferrin, confirmed iron deficiency. To some extent this 
could be accounted for by a slight reduction in the amount of 
iron provided by a qualitatively normal diet. An intact 
absorbing mechanism was documented by ready response to oral 
supplementation. Haemosiderinuria could not be demonstrated 
whereas iatrogenic blood loss was known to result from 
sampling during the aphereses. 
HAEMOLYSIS AS A CAUSATIVE MECHANISM 
Screening tests in the form of lactic dehydrogenase and 
free plasma haemoglobin were within the normal range. As an 
indirect reflection of shortened survival, stimulated 
erythropoiesis was demonstrated by a shift in the 
reticulocyte maturation index coupled with a 
pattern of glucose-6-phosphate dehydrogenase 





significantly shortened in cases studied prior to commencing 
treatment thereby establishing haemolysis as a new finding in 
these hypercholesterolaemic individuals. Placement of an 
arteriovenous fistula, followed by the exchanges, led to 
significant iron loss in discard fluid and urine: this finding 
necessitated the use of ICP-AES and was correlated with the 
gradual depletion of body stores. This set of circumstances is 
explicable on the development of an additional intravascular 
component to an already reduced mean life-span. 
THE RED CELL LESION 
Whilst iron deficiency may impair the integrity of red 
cell membranes it was interesting to recognise that 
cholesterol, taken-up in proportion to the prevailing plasma 
concentration, might similarly alter their behaviour. 1
2 , 13 
Ektacytometry was used to demonstrate reduced deformability 
and increased fragmentation occurring in vitro under 
conditions of stress calibrated to approximate those 
prevailing during flow in the microcirculation. 
A UNIFYING HYPOTHESIS 
Homozygosity for defective expression of the low density 
lipoprotein receptor results in severe hypercholesterolaemia. 
A reduced mean red cell life-span, existing prior to 
commencing plasma exchange, hints at a lipid-associated 
contribution to the haemolysis particularly since iron 
nutrition, reflected in serum ferritin levels, is well 
preserved in comparison to corresponding values in patients on 
treatment. Interpretation of this association is difficult 
because one of the cases has had a portacaval shunt and 
additional affected individuals were not available for study. 
6 
Given this caveat it can nevertheless be speculated that 
the effete red cells are slightly more rapidly removed by the 
reticuloendothelial system. Such a mechanism is essentially an 
enhancement of the physiologic pathway whereby extravascular 









first seen. Thus 
by erythropoiesis 
accelerating to keep pace with shortened survival. 
However any additional stress, as would occur with the 
turbulence created by passage across arteriovenous fistulae or 
during plasma exchange, is likely to be poorly tolerated by 
these fragile membranes. In this context any degree of 
intravascular haemolysis, favouring long-term iron loss in the 
discard fluid and urine, creates an extra need that cannot be 
met from a diet that is, in the first place, only marginally 
adequate. As red cells become hypochromic and microcytic they 
deform even less readily and potentially compound the already 
reduced survival. 
PERSPECTIVE 
Apart from documenting this association between plasma 
exchange and the development of iron deficiency anaemia there 
is direct relevance for patient management. Thus the simple 
expedient of providing oral supplementation to overcome loss 
during chronic plasmapheresis prevents the development of 
paradoxical hyperviscosity14 attributable to added rigidity of 
the iron deficient cells . 15 Such minimal intervention 
circumvents symptoms due to this type of anaemia and may also 





Cardiovascular disease, primarily in the form of atheroma 
affecting the coronary and cerebral circulations, remains one 
of the foremost causes of morbidity and mortality on a world-
wide basis. There are striking differences between the very 
high incidence in Westernised societies and much lower levels 
found in Chinese and rural African Blacks. This discrepancy 
highlights the importance of predictive factors and, of these, 
elevation in the plasma cholesterol is of acknowledged 
significance . 1 7 ' 18 It is therefore not surprising that vast 
amounts of time and money have been invested in seeking to 
accurately identify the role of this essential lipid in 
pathogenesis and then to design intervention strategies to 
blunt its impact on both vascular events and survival.
19 
A logical approach starts with epidemiologic studies to 
locate high-risk populations such as the Afrikaners 20 , 21 and 
then to apply appropriate techniques to define causative 
cellular and molecular biologic mechanisms. These objectives 
find common ground in genetically determined familial 
hypercholesterolaemia (FH) with prevalences of homozygotes and 
heterozygotes, at least in Transvaal Afrikaners, calculated to 
be one in thirty thousand and one in one hundred 
respectively. 22 Even here there exists a clinico-pathological 
spectrum within the homozygotes and, as anticipated, lesser 
severity where there is a heterozygous pattern of 
transmission. 22 This experiment of nature, so well illustrated 
8 
in our local population yields, regrettably, individuals who 
are refractory to dietary manipulation and drug therapy but 
can be controlled by serial plasma exchange. 10 When this 
modality is employed over extended periods of time, it is 
clearly beneficial whether apheresis or affinity-columns are 
used. Thus reduction in cholesterol level occurs promptly and 
is sustained while clinical outcome over the longer term is 
improved. 11 
Immediately following the procedure alterations in plasma 
protein and other components are relatively well characterised 













plateletapheresis is quantitative alterations in T-lymphocyte 
subsets. 23 More striking is the previously unreported but 
gradual development of hypochromic and microcytic anaemia 
which cannot be accounted for by an inadequate diet. That the 
problem does not lie with absorption is proven by prompt 
response to oral iron supplementation. Since haematologic 
values are normal at presentation a novel concept is that 
reduction in red cell mass is the end result of protracted 
periods of additional blood loss where one source was specimen 
collection and another was intravascular haemolysis that may 
complicate cell separation. 6 Thus it can reasonably be 
speculated that erythrocytes in the homozygous state are 
rendered abnormal by the high lipid environment 1n which they 
circulate. Under the latter circumstances they undergo 
accelerated physiologic removal by the reticuloendothelial 
system which is an iron-conserving extravascular pathway. 
9 
Compensatory mechanisms stimulate erythropoiesis and a younger 
population is released in numbers adequate to maintain normal 
blood counts, at least when viewed superficially. 
However, when such fragile cells undergo further stress, 
at points of turbulence created by arteriovenous connections 
established to maintain ready vascular access, or when 
compounded by passage through the long extracorporeal plastic 
circuit in the separators, two events take place. Firstly, 
there is acceleration in extravascular breakdown and secondly, 
intravascular haemolysis develops. The latter culminates in 
iron being lost with the discard plasma as well as urine and, 
if continued long enough, ultimately contributes to depletion 
of stores and falling haemoglobin. Apart from the purely 
scientific interest of testing this hypothesis there is a 
pragmatic consideration in needing to recognise that the 
evolution of such a conditioned nutritional deficiency brings 
with it new symptoms. These side effects can be averted by the 
simple expedient of providing oral iron supplementation. 
Other haematologic complications of aphereses, that may 
predispose these individuals to varying degrees of morbidity, 
are all rare. They include impaired phagocytic function, 
potential disturbances in humeral or cell-mediated immunity24 
or where platelet activation may follow exposure to foreign 
surfaces and create a risk for acute thrombotic events. 25 
This literature review has therefore been undertaken to 
place in perspective the impact of long-term plasma exchange 
required to control the lipid abnormalities with particular 
emphasis on the pathophysiology of the anaemia and, where 
10 
appropriate, to document other haematopoietic changes that may 
occur. 
CHOLESTEROL PHYSIOLOGY 
Source, Synthesis and Function 
This amphipathic lipid is water insoluble forming, as it 
does, an integral component of many body cells where it 
participates either free or covalently bound to fatty acids to 
yield an ester suitable for intracellular storage. The diet 
contributes about half of the body pool being derived from 
meat, liver and egg yolk with the remainder endogenously 
synthesised by the liver, and to a lesser extent, the 
gastrointestinal tract and skin. In these pathways the rate of 
formation is limited by 3-hydroxy-3-methyl glutaryl coenzyme A 
reductase or HMG-CoA reductase. 26 Understandably the latter 
becomes the target for modern therapeutic approaches used 
singly27 or in combination. 28 , 29 
Cholesterol is the precursor of adrenocortical and sex 
hormones as well as bile acids with the lipid itself appearing 
in gall stones: earlier in the pathway squalene can give rise 
to vitamin D rather than this coming from cholesterol itself. 
Normal cell function is critically dependant upon plasma 
concentrations and when this drops below 150 mg/dl, which is 
equivalent to 4 mmol/L, may be associated with increased 
mortality from non-coronary causes30 but this may be related 
to the drugs rather than the reduced serum level. 31 It is 
noteworthy however that these concentrations are seldom, if 
ever, encountered in homozygous familial 
hypercholesterolaemia. 
11 
Transport and Excretion 
Poor solubility in biological fluids is compensated for 
by transport within lipoproteins. These comprise 
apolipoproteins that non-covalently associate with free or 
esterified cholesterol. When complexed in this way movement is 
facilitated from the gastrointestinal tract following 
absorption, as well as from sites of synthesis mainly in the 
liver to points of utilization. Additionally the high density 
fraction moves free cholesterol from tissues to the liver, in 
what is termed the reverse transport pathway, for subsequent 
conversion to bile salts. In this form approximately half is 
lost in the faeces as bile acids or their salts and the 
remainder excreted as neutral steroids (Figure I). A portion 
of the free cholesterol in the bile is reabsorbed in an 
enterohepatic circulation. Additionally some of the 
cholesterol that serves as a precursor for faecal steroids is 
derived from the intestinal mucosa: 26 a very minor pathway. 
PATHOPHYSIOLOGY OF HYPERCHOLESTEROLAEMIA 
Elevation in cholesterol is a marker for coronary and, 
less frequently, cerebral vascular disease with the most 
serious effects evident in those with FH. 32 ' 33 Within this 
group the plasma level was noted 









demonstrate that this partly reflected different mutations in 
the low-density lipoprotein (LDL) receptor. The latter is a 
single-chain glycoprotein that contains 839 aminoacids when 
mature and is encoded for by a gene on the short arm of 




A. BILE ACIDS 















Plasma cholesterol is derived from the diet in an exogenous 
pathway and endogenously synthesised by the liver. Its 
clearance, particularly of the low density lipoprotein 
fraction, is predominantly mediated by the cognate receptor 
largely on hepatocytes. 
13 
reflecting an inherited defect in its gene, has the capacity 
to disrupt normal control of cholesterol metabolism.
35 
Genetics 
Mutations of the normal LDL receptor gene influence its 
biophysiology with sub-division between three and five major 
classes (Table 1) . 3 5 - 3 7 This is an autosomal dominant 
condition and thus the heterozygous form is much more common 
in the general population. Our interest centres on South 
African studies where a founder effect is evident in 
geographically isolated ancestral populations, 
9 notably the 
Afrikaners. Furthermore plasma cholesterol levels in the 
heterozygotes are generally between 7.5 and 12 mmol/L whereas, 
in homozygotes, this is typically in the range of 15-25 
mmol/L. 
In homozygous FH genetic defects that impair rather than 
abolish receptor function tend to produce lower plasma 
concentrations of cholesterol. Such patients are more 
responsive to treatment which consequently results in less 
severe degrees of cardiovascular disease. This point has 
recently been reviewed in detail. 21 , 35 
Since some individuals having the same receptor defect 
show systematic differences in LDL cholesterol concentration 
the existence of modulating genes was postulated and 





The lipoproteins may 
on the phenotype 
be classified 





CLASSIFICATION OF LDL RECEPTOR MUTATIONS 
CLASS 
I Failure to produce any detectable receptors. 
II Receptors failed to mature normally. 
III Receptor binding to lipoproteins is poor. 
IV Lack of receptor internalisation. 
V Failure of receptors to recycle. 
One hundred and fifty different mutations have so far been 
described and these code for membrane defects that variably 













Chylomicrons VLDL IDL LDL 
800-5,000 300-800 250-350 180-280 
<0.94 0.94 ·1.006 1.006 · l.019 1.019 -1.063 
Remains at 
Pre-beta Slow pre-beta Beta origin 
Dietary Endogenous Cholesteryl ester, Cholesteryl 
triglycerides triglycerides tri@ycerides ester 
A-I A·Il A-IVB-48 B-100 C-1 C·Il B-100 C-IDE B-100 
, , , , , ' ' 







A-I A-II C-1 C-II ' ' , , 
C·ill,D,E 
The lipoproteins are classified into their major groups based 
upon size, reflected in diameter, density, electrophoretic 
mobility as well as lipid and protein content. The 
apolipoproteins act as co-factors for enzymes or as ligands 
for receptors and in this way are centrally involved in the 
metabolism of lipoproteins. 
16 
Firstly the apolipoproteins are currently allocated to 
one of five groups designated A to E. The apo-B 100 functions 
as the ligand or attachment site for the low density 
lipoprotein (LDL) receptor. 
These molecules, together with their major lipids, give 
rise to the lipoprotein complex. These fall into five sub-
types or classes designated chylomicrons, very low density 
lipoproteins or VLDL, intermediate, LDL and high density 
lipoprotein or HDL. While interactions between them are 
important most current interest centres on the · low-density 
fraction which, through apolipoprotein B-100, is recognised by 
its cognate receptor expressed on cell surfaces including, 
particularly, the hepatocyte. 
THE CLINICAL SPECTRUM 
Heterozygotes 
Such individuals have a prevalence that varies worldwide 
from about one in five hundred to one in one hundred among 
Afrikaners and a plasma cholesterol that is typically between 
7.5 and 12.0 mmol/L at birth with LDL two to three times above 
the mean normal value and HDL less impressively raised. This 
biochemical finding may be the only evidence of disease during 
the first decade of life. From the age of ten years corneal 
arcus, thickened tendons and xanthomas appear: in the third 
-
decade the latter features are universally found and presage 
the onset of symptomatic coronary artery disease with early 
myocardial infarction.3 3 
Homozygotes 
This inherited metabolic disorder has 




thousand in Transvaal Afrikaners. 22 Biochemically there is 
hypercholesterolaemia greater than 15 mmol/L present at birth 
and persisting throughout life with variations being accounted 
for by the type of mutation present. Those with mean plasma 
levels of 16.1 mmol/L have the exon three mutation as opposed 
to the greater value of 26.7 mmol/L when the 10kb deletion is 
present. 34 These figures translate into a higher death rate 
for the latter group. LDL is typically raised six times above 
physiologic levels with HDL slightly lower and triglycerides 
normal or minimally increased. 
Clinically there are striking plaques or lemon-orange 
coloured xanthomas and tendon thickening both of which are 
evident shortly after birth and have inevitably developed 
before the age of four. Corneal arcus does not unusually 
manifest in the first decade. The striking feature is rapidly 
progressive atherosclerosis with childhood onset of angina 
pectoris, classical electrocardiographic changes of ischaemic 
heart muscle and obstructive atheromatous lesions evident on 
angiocardiography. Myocardial infarction is frequent with 
death often within the first 30 years of life. Unexplained are 
episodes of polyarthritis and tenosynovitis. 33 In some 
instances the features are those of aortic ejection systolic 
murmurs due to supravalvular stenosis. 22 
Diagnosis is currently best confirmed with DNA-based 
studies and, if this is conducted as part of an ante-natal 
screening programme, offers parents the option of considering 
termination. However it should be noted that this would be 
contentious in a disorder where effective treatment is 
18 
available and some cases have survived for long periods of 
time without major intervention. 
Certain well described although unusual haematologic 
abnormalities occur in this setting. Importantly red cell 
damage seems not to have been reported and most notably 
anaemia is not a recognised association. Conversely 
hypercholestrolaemia affects platelet function and their 
survival both experimentally as well as in human disease. 39 
Also relatively poorly characterised are changes in leucocytes 
from such patients which, nevertheless, 
morphologically and when examined with flow 
are abnormal 
cytometry. 40 
Intravascular coagulation may be disturbed in these 
individuals with alterations in antithrombin III levels and 
fibrin or fibrinogen degradation products. When taken in 
conjunction with platelet lesions diverse rather than any 
uniform effect emerges. 41 
TREATMENT 
Heterozygotes 
Diet was previously advocated to limit total cholesterol 
to 300 milligrams a day for adults and half this for children 
with decrease in unsaturated fat intake and saturated products 
increased. However it is noteworthy that most clinicians would 
favour even more strict control than these older guidelines. 
Weight reduction is beneficial in those who are above the 
ideal body mass and regular exercise is helpful in lowering 
triglyceride and LDL level whilst elevating the high density 
lipoproteins. Dietary control is, however, seldom sufficient 
and invariably pharmacologic intervention is required . 
19 
Drugs are most effective when combined with reduced lipid 
intake. 
Bile acid sequestrants, such as cholestyramine, are non-
absorbable resins that sequester cholesterol retaining it 
within the intestinal tract leading to significant loss in the 
faeces: consequently the amount available for lipoprotein 
production by the liver falls markedly. 42 , 43 Furthermore, by 
increasing cell surface receptors for LDL, it is possible to 
bring about a 20 to 30 percent reduction of this lipoprotein 
whereas those for high density molecules may rise 5 to 10 
percent. 43 Since these therapeutic agents are not absorbed 
systemic toxicity does not occur: they are however unpalatable 
and lead to poor compliance. 
Nicotinic acid or niacin is a water soluble vitamin that 
reduces the flux of non-esterified fatty acids to the liver 
with a consequent reduction in lipoprotein secretion. 43 It can 
lower cholesterol by 20 to 30 percent, triglycerides between 
20 and 60 percent and may lead to a rise in high density 
lipoprotein by 20 to 30 percent. Unfortunately the dose 
required is associated with significant side effects. 
Probucol has an uncertain action but appears to enhance 
non-receptor mediated LDL clearance. Although plasma levels 
drop 5 to 15 percent it, at the same time, decreases HDL by up 
to 25 percent and is therefore not widely used at the present 
time. 43 
Fibrates such as bezafibrate, fenofibrate, 
gemfibrozil act by accelerating the activity of lipoprotein 
lipase so that triglycerides fall some 30 to 60 percent, serum 
cholesterol 5 to 20 percent whereas HDL rises 10 to 15 
20 
percent. These changes are well tolerated and associated with 
few if any symptoms . 43 
Three-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) 
reductase inhibitors such as simvastatin, pravastatin and 
lovastatin11 , 27 , 44 inhibit the enzyme which is rate-limiting 
for cholesterol synthesis and thereby deprives intracellular 
metabolic processes of this essential precursor. In 
consequence there is forced up-regulation of the LDL receptor 
in order to compensate for its limited availability with 
faster clearance of LDL and consequential decrease in serum 
concentrations. These are promising agents and have the most 
dramatic effect of all drugs in decreasing LDL cholesterol in 
the heterozygous FH and persons with normal LDL receptor 
status. There are only minor symptoms with tolerance usually 
being good. Although low cholesterol levels are associated 
with behavioural changes these are seldom found in FH and, 
indeed, there is a question as to whether adverse effects may 
not be related to the drug itself. 45 
Partial ileal bypass produces some therapeutic impact in 
heterozygotes and is approximately equivalent to that achieved 
with bile sequestrants such as cholestyramine. 46 
Plasmapheresis has been used but evidence that it is 
clinically useful is less convincing than in homozygotes. It 
seems to offer no real advantage over conventional therapy. 
The preferred treatment is by strict attention to diet 
combined with one or other of the drugs and, of these, HMG CoA 
reductase inhibitors are most effective in reducing both serum 
cholesterol and particularly the LDL fraction. 
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Homozygotes 
Diet is essentially similar to that employed in the 
heterozygous state but here it is relatively ineffectual 
although nevertheless useful. 
Portacaval anastomosis has been created in a number of 
these individuals. However, the outcome of this surgical 
procedure is variable but, in a percentage of cases, 4 7 may 
reduce cholesterol by up to fifty percent: a further advantage 
is impaired synthesis of bile salts that bring about drop in 
LDL concentration. 
Drugs are effective but the extent to which this occurs 
is determined by the presence or absence of LDL receptor 
binding activity. If mutations have abolished this function 
all forms of therapy are valueless. In contrast retention of 
even varying degrees of ligand-binding can result in 
significant lowering of the cholesterol level by diet in 
combination with one or other of the same agents employed in 
managing the heterozygote. Generally speaking lipid-modifying 
agents are not, however, routinely employed in homozygous FH. 
Plasmapheresis is successful and a widely employed 
therapeutic option for direct removal of the of fending LDL: 
this includes the variation in which affinity columns are used 
to selectively deplete just the particular fraction. Either 
way these aphereses procedures are well tolerated but require 
lifelong performance with intervals of one to two weeks. 













homozygotes. As more than three quarters of the total receptor 
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population in the body are located on this organ, there is 
rationale for such an aggressive approach. These individuals 
then become responsive to drug therapy that will stimulate 
activity of these LDL - binding structures. 50 
Gene therapy is promising and animal studies have 
demonstrated that sustained and safe lowering of LDL can be 
achieved: this offers an attractive therapeutic option for the 
future. 51 
APHERESIS TECHNOLOGY 
Impact on Cholesterol 
In general terms this is adjunctive to optimum 
combination of diet and receptor stimulating drug programmes. 
These procedures are used relatively infrequently in 
heterozygotes but are the cornerstone of treating patients who 
are homozygous particularly where the mutation is such that 
alternative and less invasive approaches are ineffective. 
Plasma cholesterol levels can be reduced by half provided 
these are carried out on a long-term basis. 52,53 
Centrifugal Separators 
Introduced in the early 1950's for collecting blood 
cells, these instruments have undergone extensive 
technological improvement in the last four or more decades. 54 
The modern versions are efficient and safe in that the older 
polycarbonate bowls have been replaced by disposable plastic 
lines. The principle is fractionation of whole blood in a 
centrifugal field based on particle density. The process may 
be either continuous or intermittent55 but in either of these 
two cases there is non-selective removal of the plasma 
together with all that it contains including both low and high 
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density lipoproteins. Apart from safety the latest generations 
are fully computerised, relatively inexpensive to operate and 
have a high degree of patient acceptability. 
Filtration Techniques 
These depend upon the isolation and retention of cells 
either by passage through flat cellophane sheets or hollow 
nylon fibres. 54 The process is governed by size of the 
molecule and efficiency determined by a number of variables 
that include packed cell volume, viscosity, flow rate, number 
and dimensions of the channels in the mod.ule. S6 The 
extracorporeal blood volume is usually small and an almost 
totally cell-free discard readily achievable. 
Immunoadsorption Colwnns 
Plasma, which can be prepared by any of the different 
methods, is perfused through an affinity column which contains 
a dextran sulphate-cellulose gel base rich in binding sites 
for low density lipoprotein cholesterol. 49 , 57 Alternatively an 
anti-human LDL antibody, directed against apolipoprotein BlOO, 
is coupled to a sepharose matrix. 58 In both cases the 
offending fraction can be specifically depleted while other 
components are returned to the patient thus obviating the need 
for any form of fluid replacement. 49 
The HELP or Heparin Extracorporeal LDL Precipitation System 
Flocculation of lipids with heparin can be achieved at 
acidic pH. These large insoluble complexes are then simply 
removed by filtration: 59 . it should be appreciated that there 
is an associated and often marked reduction in 
fibrinogen. 59 , 60 
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Immediate Complications 
Vascular access is critical to ensure the high blood flow 
that is necessary for efficient procedures. Frequently 
antecubital vessels are inadequate and, for this reason, 
femoral, jugular or subclavian veins may need to be cannulated 
or even arterio-venous f istulae or shunts created. 61 In the 
latter situation hazards include loss of a distal arterial 
segment, stroke or even gangrene. Other significant problems 
i nclude haemorrhage, thrombosis and infections. 62 
Replacement fluid needs to be carefully constituted. Use 
of simple 
proteinaemia, 
electrolyte solutions may result in hypo-
hypovolaemia and drop in blood pressure. 63 This 
can be circumvented by addition of albumin or group-specific 
fresh frozen plasma. However the latter should not be used on 
its own in chronic programmes particularly for 
hypercholesterolaemia because it does not, as efficiently, 
reduce the lipoprotein levels. Additionally this material may 
be associated with allergic reactions including urticaria and 
pruritus. Brisk haemolysis can occur unless group-specific ABO 
serum is used to circumvent the possibility of a high titre of 
naturally occurring IgM antibody destroying the recipients red 
cells. 62 
Albumin can cause unpredictable pyrexia with aching 
joints and a feeling of fatigue: neither of these are 
classical pyrogenic events and despite considerable 
investigation their mechanism is unexplained. 64 Conversely, 
allergic reactions of variable severity may occur when 
individual units contain small amounts of antigen to which the 
r ecipient has previously been sensitised and these may vary 
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from such things as food proteins to medication, for example, 
sulfonamides or penicillin. 
Circulatory effects generally reflect failure to 
accurately balance extracorporeal loss of fluid although most 
modern instruments have an electronic circuit with alarms to 
indicate the development of such disequilibrium. Symptoms of 
hypovolaemia are often rather non-specific with malaise, 
headaches, tiredness or cramps but late signs include 
these tend to be more abdominal · pain, vomiting and collapse: 
pronounced with increasing age. At the other extreme is 
cardiovascular overload that may cause pulmonary oedema 
particularly in the elderly. Meticulous attention to detail 
and maintenance of isovolaemic exchanges should, certainly in 
experienced hands, be sufficient to avoid such occurrences. 62 
Heparin anticoagulation is an effective approach but it 
is important that overdosage not occur since this can lead to 
haemorrhage. Conversely, 
thrombi forming in the 
inadequate quantities predispose to 
circuit. 62 This is associated with 
reinfusion of partially clotted material that has procoagulant 
activity and may result in disseminated intravascular 
coagulation or cell breakdown in the separator. In patients 
undergoing column-based procedures that involve dextran 
sulphate, hypocoagulability is sometimes found as factors V, 
VIII and X are adsorbed and then lost. 65 
Calcium chelation and citrate toxicity have both been 
well characterised. 66 The hypocalcaemia required to prevent 
blood clotting may be associated with neuromuscular 
hyperactivity, sensory disturbances, circumoral parasthesiae, 
nausea and vomiting: shaking chills may arise and progress to 
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tetany while cardiac arrhythmias can also occur. All of these 
emphasise the importance of careful non-invasive monitoring 
during the entire run. 62 , 66 Most of the side effects are 
preventable by prophylactic supplementation with oral calcium 
salts or titrated doses of either the chloride or gluconate 
given intravenously during the course of the exchange. Citrate 
toxicity will be aggravated when the replacement fluids 
contain large amounts of plasma contaminated with this anion 
or in the presence of renal failure where its metabolism is 
impaired. 
Effect on medication is markedly influenced by these 
procedures. Thus many low molecular weight substances are 
rapidly removed and accordingly schedules need to be adjusted 
after completion of the apheresis so that therapeutic levels 
are reinstituted. Examples include anti-epileptic agents or 
cholinesterase inhibitors. 67 This phenomenon is particularly 
troublesome with drugs that are protein-bound since such 
complexes are efficiently cleared from the circulation. 
Haemolysis may arise for a number of reasons. For example 
hypotonic fluids may bring about severe degrees of red cell 
breakdown. 68 In addition blood exposed to turbulence during 
mechanical separation develops subliminal alterations in 
erythrocyte membranes which can lead to accelerated removal 
probably by the reticuloendothelial system. This is a bigger 
problem with discontinuous flow instruments and, whilst 
infrequent, it is mandatory that the operator continuously 
checks the plasma for colour change and randomly measure free 
haemoglobin spectrophotometrically. 62 
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Air embolism is a hazard but should not occur with 
meticulous attention to technical details. When this takes 
place and it is of small volume, symptoms and signs are 
transient. Occasionally severe and irreversible cerebral 
damage or cardiac arrest arise when the connectors become 
detached or the tubing is faulty so that air obstructs small 
but vitally placed arteries. 62 Complaints include chest pain, 
shortness of breath, extreme anxiety, a drop in blood pressure 
wi th sweating and syncope. Alert staff will detect malfunction 
since modern equipment has alarms and other suitable warning 
devices. Nevertheless it is impossible to over emphasise the 
importance of constant supervision. 
Delayed Effects 
Haemorrhage is relatively unusual and takes two forms. 
With some of the older instruments loss of red cells in the 
discard tubing was sufficient to deplete iron stores. 
Interestingly a similar situation of iatrogenic phlebotomy can 
occur with frequent blood sampling. Alternatively blood loss 
may develop acutely. Rarely, only once in my experience over 
two decades with many thousands of procedures, has a patient 
left the unit and developed a major bleed from the femoral 
site. This was probably mechanical and responded to local 
pressure: the clotting factors on assay did not significantly 
differ from the reduced values normally found after plasma 
exchange. 69 A contributing factor can be loss of platelets 
which, with properly scheduled intervals, do not reach levels 
usually associated 








hypocoagulable states, has not been described as a cause for 
this complication. 
Thrombosis may be precipitated by removal of naturally 
oc curring anticoagulants such as antithrombin rrr. 70 Although 
apparently not studied it would be reasonable to anticipate 
that concurrent loss of the proteins C and S would occur. If 
this were so, one consequence, theoretically at least, might 
be predisposition to hypercoagulability. 
Bacterial infections seldom arise despite some decrease 
i n immunoglobulins although, where patients additionally 
receive immunosuppressive therapy, they become susceptible to 
this possibility. 61 , 62 , 71 
Viral infections are also a risk particularly where 
plasma is used and here rational concerns extend to the retro-
viruses most notably that causing the acquired 
immunodeficiency disease. All products need to be drawn from 
donor panels that have been carefully screened and recent 
evidence has shown that this care needs to extend to freedom 
from hepatitis c. 72 
Protein depletion results only when serial exchanges are 
carried-out and the replacement does not contain albumin. This 
may lead to subtle development of hypoproteinaemia, loss of 
oncotic intravascular pressure and dependant oedema.6l,62,63 
Chills may be troublesome if the room temperature is too 
low. However they are also found when the individual is unable 
to change position 
infusion of cold 
frequently or in 
exchange fluid.62 
association with the 
When immunoabsorption 
columns containing sheep antibodies are used there may, in 
addition, be fever and flushing. 73 
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Morbidity and mortality are significant although 
infrequent occurrences. Fifty deaths have been reported of 
which 30 were due to either acute cardiac arrhythmia or 
refractory pulmonary oedema. 61 The complication is generally 
reported as being in the region of three per 10,000 
procedures. 61 
Haematologic Consequences 
Erythrocytes have attracted scant attention although 
i ron-responsive anaemia 
investigated. 49 ' 74 Here, 
for depletion of stores, 
has been observed but never 
rather than examining the mechanism 
simple replacement has been employed 
for symptomatic control. However, alternative possibilities 
seem not to have been considered. For example could repeated 
blood sampling deplete stores? Is it possible that shortened 
red cell survival may exist as a consequence of the 
hypercholesterolaemia itself? If so could the latter be 
aggravated by turbulence during the extracorporeal 
circulation? This outcome is hinted at by previously reported 
acute intravascular haemolysis albeit that the patient was 
receiving cyclophosphamide . 6 
Leucocytes of both major categories become dysfunctional. 
Although neutrophils are affected this seldom translates into 
clinical important infections in our experience . Conversely, 
lymphocytes are quantitatively and qualitatively altered in 
the closely allied technique of plateletpheresis and here 
significant and long-lasting alterations in function have been 
documented. 23 , 75 By the same token monocytes are known to be 
activated, perhaps by contact with foreign surfaces such as 
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the plastic, and then release cytokines with a variety of 
different effects. 76 
Platelets often drop by 15 to 50 percent depending upon 
the instrument used. 1 Of note is the observation69 that 
thrombocytopenia universally develops acutely but seldom much 
below the lower limit of normal. Even if aphereses are 
carried-out serially, and allowing for the direct loss into 
the discard fluid, recovery is prompt and usual. It has 
furthermore been shown, using f low-cytometry, that platelet 
activation occurs in the hypercholesterolaemic pat1ent and, of 
note, is the fact that these procedures reverse this defect. 77 
The coagulation proteins influence prothrombin and 
partial thromboplastin times with both increasing modestly 
although return to baseline is usual within 24 hours. 1 , 69, 78 
Other data showed that they would only be prolonged if the 
fibrinogen level fell to approximately 500mg/L.69,71 
Interestingly clotting factor concentrations are depressed in 
direct proportion to the volume of fluid exchanged but may be 
reduced up to 50 percent of the pre-treatment values and often 
remain down for up to 72 hours. 1169 It is important to 
appreciate that in such situations, where aphereses are 
carried-out daily, it is possible to lower this protein 
sufficiently to cause bleeding. 69 
The remaining clotting factors also drop between 25 and 
50 percent of their physiological values and these low figures 
loosely correlate with large substitutions. 1171 , 78 , 79 Data are 
available on II, VII, XI and XII with V and VII usually being 
fully corrected in 24 hours while the others typically remain 
reduced for twice this period. 79 
31 
Conversely thrombosis may be predicated on the basis of 
significant decreases in antithrombin rrr 70 as well as in the 
protein c-s system although data for the latter is sparse. 
Less clear is evidence that qualitative haemostatic 
abnormalities play any clinically relevant role. 
Immunoglobulins are frequently affected by plasma 
exchange1180 but this seldom translates into any problem with 
bacterial or other infections. 
The complement system is made-up of a family of proteins 
which, once activated, convert C3 and CS to the 
anaphylatoxins C3a CS a. 76 The extent to which these changes 
occur is probably influenced by the nature of the artificial 
surface and the conditions under which the procedure was 
carried-out. Thus there is an important role for choice of 
anticoagulants, whether this be citrate or heparin, since the 
former, by chelating calcium, inhibits the conversion of inert 
to functional components. 76 
Because of these risks much research has been devoted to 
the fabrication of plasmapheresis membranes from synthetic 
polymers such as polypropylene and this technology reflects 
the world-wide importance attached to developing bio-
compatible artificial surfaces in an attempt to reduce the 
generation of C3a and CSa. 81 
In an early study with plasma separation achieved by 
centrifugation there was a decrease in total haemolytic 
complement or CHSO as well as the C3 and C4 sub-fractions. 
However all of these returned to normal within 24 hours but 
C3a and CSa were not directly measured. 1 
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CONCLUSION 
Long-term plasmapheresis is a 
effective form of therapy in 
well established and 
managing homozygous 
hypercholesterolaemia. The observation that anaemia occurs was 
interesting since it appears to have passed unnoticed other 
than for an oblique reference to the occasional individual who 
responded to iron. It is therefore particularly notable that 
the pathophysiologic mechanisms depleting body stores have 
attracted no attention. Since this is clearly of significance 
a prospective study was undertaken to define the· incidence, 
characterise erythrocyte morphology and specifically explore 
aetiology. An additional objective was to establish whether 
any intervention was beneficial 
complication and, if so, whether it 
improve the quality of life. 
in preventing this 






Seven representative individuals with familial 
hypercholesterolaemia were ref erred for plasma exchange 
between 1976 and 1993 (Table 3). This procedure did not 





erratically and only for short periods. 
further reference is made to data from these 
Twelve patients were entered on protocol study during the 
same period. All had xanthomata of the Achilles tendon, 
interdigital cutaneous deposits, ejection systolic murmurs of 
supravalvular aortic stenosis whereas corneal arcus was 
present in all but three. An ileofemoral bruit was present in 
one. Three, presenting with angina pectoris, underwent 
coronary artery bypass grafting of whom one required an 
additional valve replacement. Family studies are available in 
six instances (Figure IIa, Figure IIb and Figure IIc). 
Two of the 12 died from acute myocardial infarction and a 
third refused therapy (Table 4) . Another three, who were 
eligible, formed a non-exchange control group because, one 
declined to participate, venous access was impossible in a 
second and severe ischaemia has required surgical intervention 
in the third (Table 4). 
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INITIALS YOB SEX 
D.E. 1948 F 
A.J. 1937 F 
A.A 1944 M 
A.Z. 1931 M 
A.H. 1935 M 
J.P. 1929 F 
S.P. 1928 F 
TABLE 3 
HETEROZYGOTES 
TC HDL LDL 
15.13 1.0 13.46 
9.14 .8 8 7.34 
11.01 1.0 9.21 
9.7 .9 6.75 
7.5 - --
8.9 1.10 5.67 




1.75 DIED 10.3.88 
.84 LTF 
1.70 DIED 18-6-82 
2.0 DIED 10-4-84 
.90 LTF 
Only the initial lipid data (mmol/L) is presented si
nce these 
seven individuals were exchanged erratically and 
only for 
short periods. They are excluded from further conside
ration. 
LTF = Lost to follow-up. 
TC = Total cholesterol. 
TG = Triglycerides. 







In these three consecutive illustrations lines extending 
beyond the symbol signify death of that person. Solid shading 
denotes homozygosity and half-filled squares or circles are 
the heterozygotes. Open symbols reflect uninvolved 
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HOMOZYGOTES - REFERENCE GROUP 
DOB SEX TC HDL LDL 
15-1-74 F 21.92 0.68 20.57 
9-11-70 M 18.20 0.73 16.68 
31-3-73 M 22.82 0.71 13.57 
26-5-70 F 9.9 1.2 8.4 
25-12-81 F 24.2 .3 23.4 
9-11-69 F 17.4 .9 16.2 
TG STATUS 
1.5 21?~~v6 







Initial lipid data (mmol/L) are available in these six 
patients. The first three participated only briefly whilst the 
r emainder .were excluded for the reasons given . 
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STUDY GROUP 
The demographic data on the remaining six is given in 
Table 5. Prior to January 1991, (Phase 1) all had failed 
protracted periods of lipid-lowering agents that routinely 
included questran, clofibrate, probucol and bezalip often in 
addition to maximally tolerated doses of nicotinic acid. 
During that year (Phase II) changes in the lipogram were 
defined in response to plasma exchange alone as a control 
period for the simvastatin trial (Phase III) completed at the 
end of 1992: these results have been reported.lO,ll The 
current study (Phase IV) undertaken to systematically 




HOMOZYGOTES - STUDY GROUP 
INITIALB, LDL TC, Fe, 
FISTULA DOB RECEPTOR LDL, TIBC, 
INSERTION A.ND A.ND HDL, %BAT. , ANOIOORAPHS 




1. Trivial oorona.ry &r~ disease wtth 2. 17-2-90 OvdM single a.res. of 40% na.rrowtng In 3 . 07-3 -91 
LOW NA NA 7-2 -62 AfrFHl/AfrFH2 mid-LAD a.rtery: 4 . 13-7 -92 M NA NA 2. Trivial a.ortlc stenos!s (PSO = 5mmHg) 6. 19-9-94 NA NA 1988: corona.ry &r~ bypa.ss 
20-04-76 
AC 17.26 NA Critic&! na.rrowtng of (L) oorona.ry a.rtery. 5 -1-79 2-6-70 
HIGH NA NA 1979: Sa.phenous vein bypa.ss gra.tt from F 
AfrFHl/AfrFHl NA NA a.arts. to LCA. 
NA NA 05-12-76 
YA 19.7 11. l 
HIGH 17.22 56. l 6 -9-66 15-3 -75 
AfrFH3 + OTHER 0 .51 20 Norm&!: no ca.rdla.c lesion F 
0 .90 36 23-10-66 
CF 16.12 11.7 
21-9-75 LOW 16.59 65.2 10-2 -66 
M AfrFHl/OTHER 0 .62 16 No s!gnlflca.nt corona.ry a.rtery disease 
1.99 21 05-03-66 
CI NEGATIVE 15.05 9.9 
Ca.pa Town2/ 13.69 67.0 2 -3 -69 12-1-61 
Norm&! Ca.pe Town2 0 .59 16 M 
1.25 40 27-04-69 
JO 16.20 11.0 Mild supra.valvular a.ortlc stenosls. 
16-6-71 HIGH 17.40 61.0 Ins!gnlflca.nt single vessel corona.ry a.rtery 6 -2 -91 
F AfrFHl/AfrFHl 0.50 16 disease. 
0 .60 37 15-3-74: Porto-ca.val shunt. 06-03-91 
These six cases were serially studied over the two year period 
of this investigation. The initial lipid data (mmol/L) is 
given in this table whereas the serial values, in response to 
plasma exchanges, have been previously reported.lO,ll 
The designation of defective receptor status as negative, low 
or high is based on skin fibroblast LDL binding studies in 
comparison with controls and refers respectively to less than 






The treatment protocol was approved by. the Ethics and 
Research Committee of the University of Cape Town and Groote 
Schuur Hospital with participation requiring informed consent 
and, in the case of minors, this was obtained from their legal 
guardians. These cholesterol-depleting exchanges were 
scheduled every alternate week, using a vein-to-vein circuit, 
and replaced one and a half times the calculated plasma volume 
on each occasion. Non-invasive cardiovascular monitoring 
(Sirecust System, model 404-lA, Siemens Medical Electronics 
Incorporated, Danvers, Maryland, USA) and maintenance of a 
written and detailed work record was routine. At completion 
any cellular components trapped within the disposable lines 
were flushed back into the patient using small quantities of 
physiological saline. After withdrawal of the needles pressure 
was applied to the venipuncture sites to prevent bleeding. 
Centrifugal Separation 
The Cobe, model 2997 (Cobe Laboratory International, 
Lakewood, Colorado, USA) continuous-flow instrument, has an 
extracorporeal capacity of approximately 280 mL and 
incorporates safety features in the form of access and return 
monitors as well as air detectors.55,82 
Air was displaced from the tubing by priming, over a 30 
to 40 minute period, with 0.9 percent sodium chloride (Adcock 
Ingram, Johannesburg, South Africa) to which was added acid-
citrate dextrose solution USP formula A (ACD-A) : (Baxte'r 
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Health Care Corporation, Fenwal Division, Deerfield, Illinois, 
USA) in a ratio of 10 to 1. 
Venous blood, at a flow rate between 40 
minute, is pumped into the single-stage band 
60 mL per 
(Figure I I I) 
rotating at a speed of 1400 revolutions per minute with cell 
separation being achieved in approximately 2 minutes. At this 
point plasma is diverted to a discard bag and isovolaemic 
replacement commenced with a 5 percent albumin solution (20 
grams percent salt-free human albumin: Western Province Blood 
Transfusion Service, Cape Town, South Africa) in plasmalyte B 
(0.9 percent saline containing potassium, magnesium and 
bicarbonate: Baxter-Travenol Laboratories, Deerfield, 
Illinois, USA). To avoid changes in body temperature an in-
line warmer (Model 4R 4306, Fenwal, Baxter-Travenol 
Laboratories, Deerfield, Illinois, USA) was employed. 
Anticoagulation was maintained by a monitored addition of 
ACD-A at a ratio of 1:11 at the site of the collection needle 
and this step was checked by a flow indicator. A small citrate 
. ef feet occurred in the patients as reflected in an 
asymptomatic drop in ionisable calcium. 3 Significant 
hypocalcaemia was prevented by prophylactic infusion of 10 mL 
of 10 percent calcium gluconate (Labethica, Cape Town, South 
Africa) for each litre exchanged and this was given at a rate 
of approximately 1 mL for every five minutes of the procedure 
and corresponds to 3.75 mEq. 
Filtration Technique 
The Cobe Centry TPE (Cobe Laboratory International, 















Anticoagulated whole blood enters the band 
A 
_J 
(A) . Once 
separation has occurred packed red cells are returned to the 
patient (B) and plasma is diverted (C) with isovolaemic 
addition of exchange fluid added to the return line. The white 
cell collection port (D) is inactive during plasmapheresis. 
In this instrument the cells are separated from plasma in a 
centrifugal field. 
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elements are retained by a microporous membrane (Figure 
IV). An extracorporeal space of only 150mL is well suited to 
management in small individuals. 82 Safety features include air 
detectors and a device to monitor transmembrane pressures. A 
useful indicator is that for displaying the ratio between 
volumes removed and replaced thereby ensuring that they 
accurately match. With such flexibility it is simple to 
achieve controlled degrees of under or over-hydration. Priming 
takes about 10 minutes using saline and ACD-A at a ratio of 25 
to 1. 
The procedure is initiated at a flow rate of 20 mL per 
minute and is gradually increased two or three fold with 
plasma separation determined by this variable and the packed 
cell volume. 
Anticoagulation is started with 50 international units 
per kilogram of heparin (Intramed (Pty) Limited, Port 
Elizabeth, South Africa) and, depending on the duration of the 
run, may be repeated although not in the last 60 minutes. 
Additionally ACD-A is continuously infused at a ratio of 1:25 
to whole blood: any untoward citrate effect is counteracted by 
incorporating 6 mL of 10 percent calcium gluconate in each 
litre of replacement fluid corresponding to 2.25 mEq of 
calcium. 
LOW DENSITY LIPOPROTEIN RECEPTOR STATUS 
Homozygosity had previously been established in all cases 
on standard clinical criteria, binding studies83 and with the 
mutations in the coding sequence defined. 9 
LIPOGRAMS 
These were serially determined before and after each 
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FIGURE IV 
THE MICROPOROUS MEMBRANE FILTER 
A 
-BLOOD PATH 
D PLASMA FLOW D 
Venous blood is pumped into one side of the system (A) , 
circulates between parallel membranes (B) . Packed red cells 
are returned to the patient (C) and plasma discarded (D). 
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apheresis and also on the discard bag. Cholesterol was 
enzymatically measured using an esterase to hydrolyse the 
esters and to assay hydrogen peroxide produced by oxidation of 
the free lipid (Cholesterol Liquicolor Kit, Human GmbH:W6204-
Taunusstein 4, Germany); high density lipoprotein cholesterol 











triglycerides by enzymatic hydrolysis of lipase followed by 
assay of glycerol (Triglyceride GPO-PAP Kit, Boehringer 
Mannheim and Company, GmbH:Mannheim, Germany). LDL cholesterol 
was then calculated by subtracting HDL and triglyceride values 
from total cholesterol. 84 
The kinetic pattern at which lipids return to their pre-
exchange levels was determined by repeating these measurements 
on four consecutive days in the week of apheresis and three of 
the following seven days. 
THE BLOOD COUNT 
This was carried-out using an automated particle counter 
(Technicon Hl, Tarrytown, New York, USA) and comprised 
haemoglobin, total erythrocytes, leucocytes and platelets 
together with differential spread. In the context of this 
study particular attention was paid to the red cell indices in 
the form of mean corpuscular volume (MCV) and haemoglobin 
(MCH) as well as concentration (MCHC) . 85 
ANALYSIS OF IRON INTAKE 
Dietary composition of each meal was calculated using 
portion size, food composition tables, 86 a standard quantities 














extrapolated to the daily intake and in turn, to ingestion 
averaged over the 28 day study period. Consideration was 
concurrently given to the presence of promoters such as 
ascorbate or inhibitors including tannate, phytates or 
phosphate that might qualitatively 
availability of this trace metal. 88, 89 
EXCLUSION OF BLOOD LOSS 
enhance or inhibit 
In females it was established, by carefully taking 
menstrual history that, from menarche to the current time, 
there had been no significant changes. In none of the 
participants had there been abdominal symptoms, alteration in 
bowel habit or colour of stools other than when these became 
dark during periods on oral iron replacement. Iatrogenic blood 
loss was calculated from sample collections. 
NUTRITIONAL STATUS 
Iron 
Serum levels and binding capacity were based upon 
colorimetric techniques as recommended by the International 
Committee for Standardisation in Haematology ICSH90' 91 and 
percentage saturation then calculated. Serum and red cell 
ferritin, reflecting stores were assayed immunoradiometrically 
by reaction with radio-labelled antibody and removal of excess 
by immunoadsorption using a commercial kit Becton Dickinson 
and Company, Orangeburg, New York, USA) 92 , 93 The same methods 
were applicable to discard fluid ·where controls were aliquots 
collec~ed prior to the exchange. 
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Vitamin B12 and Folate 
These were simultaneously quantitated in plasma 
(SimulTRAC-SNB Radioassay Kit; Becton Dickinson and Company, 
Orangeburg, New York, USA) 
SCREENING TESTS FOR HAEMOLYSIS 
Serum lactic dehydrogenase and isoforms were measured by 
agarose electrophoresis (Paragon LD- Electrophoresis Kit; 
Beckman Instruments Incorporated, Fullerton, California, USA) 
and plasma haptoglobin by nephelometry 
Marburg, Germany). 
RADIONUCLIDE INVESTIGATIONS 
Red Cell Mass and Survival 
(Behring werke, 
These were determined on day zero and 14 : in each case 
immediately prior to consecutive plasmapheresis; only minor 
modifications were made to standard methods. 
Day 0 
Red cell mass was measured as the patient came off the 
machine by injecting an aliquot of autologous venous blood 
that had previously been collected into ACD-A and labelled 
with 1.11 MBq (30µCi) of 51 - radiochromium.94,95 
Survival was carried-out over four weeks following the 
course of the same radiochromated erythroid population. 96 In 
practical terms accurately pipetted 2 ml samples, collected 
daily for the first and third week and alternate days for the 
second and fourth were lysed with saponin and the 51cr 
detected with appropriate window settings on a auto-gamma 
counter. Using these points, correction was made for elution 




Red cell mass was remeasured using 74 MBq (2mCi) of 
99mTc-label (Ultra Tag RBC Kit: Mallinckrodt Medical, Code DRN 
4350) added to 3 ml venous blood in 1 ml ACD-A. Prior to 
administration the cells were washed twice in saline according 
to ICSH recommendations, 95 2 ml aliquots were obtained at 10 
and 20 minutes after infusion and analysed with automatic 
correction for 99mTc-decay and zero-time activity derived by 
linear extrapolation on a semi-log plot. 
Erythrocyte Survival by Urinary Radioisotope Excretion 
Red cell life-span was independently estimated by 
determining loss of radiochromium in the urine99 ,lOO with 24 
hour collections made on seven consecutive days of week one 
and similarly week three. Duplicate samples were counted 
against a standard derived from a known dilution of the 
orginally 
fitting of 
chromated erythrocytes with 
exponential values without 
consideration. 
Plasma Volume 
This was determined immediately 
appropriate computer 
taking elution into 
before and after 
plasmapheresis using 0.185 MBq (5µCi) of iodinated (125 r) 
human albumin on each occasion according to established 
procedures. 95 Correction was made for background radioactivity 
by counting a sample collected before each injection. Ten and 
20 minute points were extrapolated back to zero-time on a 
semi-log plot. 
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Total Blood Volume 
This was calculated prior to day 14 apheresis as the sum 
of red cell mass and plasma volume using 125 r-human albumin 
and 99mTc-red cells. 
Blood Loss During Plasmapheresis 
The 2 to 4 litre of discard plasma was, in each instance, 
well mixed and 
plastic vials: 
two 10 ml 
samples 
aliquots pipetted into 
of fluid collected 
screw-cap 
from the 
extracorporeal circuit was treated similarly. These specimens 
were then counted against an appropriate 51cr-RBC reference as 
described above. All disposable plastic lines and residual 
fluid recovered at the completion of the run were counted in a 
suitable instrument with appropriate settings and controls. 
From these three sets of data the percentage 
radiochromated erythrocytes injected on day O and lost during 
the day 14 procedure could be quantitated. 
Red Cell Retention 
Following plasma exchange apparent retention of 99mTc-red 
cells injected on day 14 was determined by counting 10 and 20 
minute aliquots against appropriate standards. 94 
Modifications for Non-exchanged Patients 
Day 0 
Red cell mass and four week radiochromium survival, as 
well as urine-based determination, were performed as above 
except that no delay in re-injection was necessary to 
accommodate the exchange. 
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Day 14 
Red cell mass was as outlined but repeat plasma volume 
not carried-out. The second urine-based radiochromium 
measurement was performed as previously described. 
ERYTHROPOIETIC RESPONSE 
The functional integrity of the erythron was evaluated by 
reticulocyte counting and determination of the maturation 
index by flow cytometry, 101 glucose-6-phosphate dehydrogenase 
(Sigma, procedure No. 345-UV: Sigma Chemical Company Limited, 
Poole, Dorset, England), 102 and pyruvate kinase (MPR 1 
Pyruvate Kinase Kit; Boehringer Mannheim, France) , 103 with 
erythropoietin directly measured by radioimmunoassay. 104 
EKTACYTOMETRY 
Red cell deformability, in response to known rheological 
stress, was determined under a variety of conditions using a 
concentric cylinder viscometer of the couvette type (Technicon 
Ektacytometer, Saint-Dennis, France). Based on the method 
originally described by Bessis and Mohandas105 where particles 
were suspended in a viscous medium and where revolution of the 
inner cylinder creates a shear field there is alignment and 
elongation which is quantitated by a laser beam that produces 
a coherent light-scattering pattern or defraction image . 106 
The end points are seen in the osmoscan which defines the 
behaviour of intact erythrocytes to a solution of gradually 
increasing osmolality within the viscometer as an index of 
deformability of the entire cell including membrane and 
contents. 107 , 108 Secondly, deformability, as well as 
fragility, is recorded by scanning ghosts or free membranes 
suspended 'in dextran: curves are generated as forces increase 
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with revolutions going from zero to lSo. 109 ,llO In recognition 
of the fact that iron deficiency may influence these same 
measurements each of the studies was repeated after stores had 
been returned to normal by therapeutic courses of ferrous 
gluconate. 111 
IRON EXCRETION 
This trace metal was quantified in the discard fluid, 
together with the range of other elements, using standard 
inductively coupled plasma atomic emission spectroscopy (ICP-
AES) . 112 Total volumes were noted and aliquots then digested 
after which the sample was atomised into an argon plasma and 
quantitated using high-quality grating spectrophotometer for 
ultraviolet and visible regions with a photomultiplier 
detector (The Jobin-Yubon ICP Machine, model JY 70 C-plus 
Jobin, Paris, France). The advantage of the system is that no 
elaborate preparation is required while simultaneous 
measurement of a number of substances can be achieved with 
high degrees of sensitivity and accuracy. Importantly the 
technique is relatively insensitive to matrix composition and 
the spectrometer can readily be coupled to a high performance 
liquid chromatograph, an FIA device or electrothermal 






In the plasma viscosity was measured by timed passage 
through a narrow capillary tube (Viscometer 2, Coulter 
Electronics Limited, Northwell Drive, Luton, Beds, 
England) . 115 The whole blood measurements employed a cone-
plate viscometer (Wells-Brookfield Engineering Laboratories 
Incorporated, Stroughton, Massachusetts, USA) . 116 
GRANULOCYTOPOIESIS AND NEUTROPHIL FUNCTION 
Total white count and differential were carried-out 
before and after apheresis using the Technicon Hl Automated 
Particle Counter. 
Superoxide anion was measured after stimulation with 
phorbol-myristate-acetate by reduction of ferricytochrome c to 






quantitated in neutrophils after exposure to endotoxin with 
conversion of the colourless dye to a detectable formazan. 118 
The phagocytic index was defined by ingestion of heat-
killed candida albicans spores. 119 Bactericidal capability was 
evaluated by the ability of neutrophils to ingest and kill 
staphylococcus aureus120 with a modified end point being 
thyrnidine incorporation. Chemotaxis and random migration was 
determined using a standard agarose method. 121 
LYMPHOCYTE IMMUNOPHENOTYPING 
At six monthly intervals pre-exchange pattern was 
retested using a standard panel of monoclonal antibodies 
comprising CD2, 3, 4, 8, and 19122 by means of indirec~ 
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immunoflourescent microscopy (Nikon Optiphot Labophot 
Episcopic-Fluorescence Attachment 11 E,F 11 / 11 EPA 11 Nippon Kogaku 
) 123 K.K., Tokyo, Japan. 
THROMBOCYTOPOIESIS AND PLATELET FUNCTION 
Bleeding times could not routinely be included because of 
patient non-compliance. Aggregometry was carried-out before 
and after plasma exchange under standardised conditions in a 
twin-channel instrument (Cronolog Corporation, Wholeblood 
Aggregometer Model 560-VHS Linked to a Strip-chart Recorder, 
Model 707, Haverton, Pennsylvania, USA). Patient response was 
compared to normals using adenosine diphosphate in 
concentrations of O .1, O. 01 and O. 005 molar (Sigma Chemical 
Company, St Louis, Missouri, USA), collagen 15 mg/ml (Sigma 
Chemical Company), epinephrine or adrenaline 0.01 molar 
(Maybaker [SA] [Pty] Limited, Holland Park, Port Elizabeth, 
South Africa), ristocetin 1. 5 mg/ml (Sigma Chemical 
Company) _124,125 
COAGULATION PROTEINS AND COMPLEMENT 
Methods were those that have previously been calibrated 
and described. 1 These included prothrombin and partial 
thromboplastin time according to standard techniques, 126 
fibrinogen, 127 immunoglobulin,128 complement and 
complexes, 129 antithrombin rrr 130 and factor eight. 131 
BIOCHEMISTRY 
immune 
All parameters were measured on an automated system 
(Hitachi 747 Automated Discreet Analyser, Boehringer and 
Mannheim Limited, Tokyo, Japan) with sodium, potassium and 
chloride based upon ion-specific electrodes. The remaining 
' 
chemistries were determined by either calibrated enzymatic or 
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calorimetric methods using commercial kits (Boehringer and 
Mannheim Limited, Tokyo, Japan). Ionizable calcium were 









accumulated during this period 
both centrifugal and filtration 
Throughout these investigations changes in 
plasma components, such as the lipids, directly related to any 
procedure were documented and they show no deviation from 
those reported previously. 11 Of note is the ability to achieve 
the desired effect on LDL cholesterol efficiently and without 
loss of any of the surgically created arterio-venous fistulae. 
Of passing interest is the fact that this generation of 
separators is now obsolete. Those with a reusable 
polycarbonate bowl have been replaced by the Cobe Spectra. 
However the therapeutic plasma filtration unit has been 
retained for managing small individuals with their limited 
tolerance for extra-corporeal sequestration of effective 
plasma or whole blood volume. 
LOW DENSITY LIPOPROTEIN RECEPTOR STATUS 
Although not central to this long-term apheresis aspect 
of managing these patients it is instructive to note that, of 
the heterozygotes (Table 3) who are slightly older al though 
with less severe cholesterol disturbances, half have died at 
relatively early age. 
The six non-study homozygotes (Table 4) have essentially 
the same biochemical defect as the plasma exchanged group and 
the lethality of the vascular disease is reflected in their 
early death rates. 
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In considering the study cohort (Table 5) all but one are 
seen to be Friedrickson type !IA. Half these cases exhibit 
homozygosity for the Afrikaner mutation where fibroblast 
cultures showed impaired binding of low density lipoprotein to 
the cognate receptor that, in turn, resulted in the 
characteristic hyperlipidaemia. A point of some interest, 
presently unexplained, is that the molecular defect does not 
universally correlate with the phenotype in which there are 
high levels of total as well as low density lipoprotein 
cholestero1. 33 a The degree of ligand attachment, as this might 
influence availability for clearance during the exchange 
procedure, was not specifically investigated. 
LIPOGRAMS 
Effect of Creating Arterio-venous Fistulae 
Inexplicably total and LDL cholesterol marginally, 
although significantly, dropped prior to commencing 
plasmapheresis: this was not noted with triglycerides or the 
HDL fraction (Figure V). 
Impact of the Apheresis Procedure 
Mean and standard deviation for total cholesterol fell 
from 12.1 (0.9) to 3.9 (0.6) with the corresponding values for 
low and high density lipoprotein fractions being, 
respectively, 10.8 (0.9) to 3.4 (0.5) and 0.7 (0.1) to 0.3 
(0.1): the triglycerides decreased from 1.0 (0.4) to 0.5 (0.1) 
(Figure VI). This is a consistent variation being most 
striking for total and LDLC. Unfortunately there was also a 
reduction in HDL which was better preserved using affinity 
column apheresis and therefore the latter has an advantage in 



















THE EFFECT OF CREATING AN ARTERIO-VENOUS FISTULA 






Pre Poat +6 Final 
Fistula Fistula Exchanges (Latest) 
-sA -+-YA -*-CF -&-c1 ~JG 
Inexplicably total cholesterol dropped after the procedure in 
all five patients as illustrated: a similar change was found 
with the LDL fraction but this is not shown. Of note is the 
observation that neither HDL nor triglycerides fell and, 
accordingly, these changes in levels are not shown. The 
vertical axis is total cholesterol in mmol/L: the horizontal 
axis is ari arbitrary scale and not in months. 
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FIGURE VI 
IMPACT OF THE APHERESIS PROCEDURE 
TC TG HDLC LDLC 
~Pre CJ Post 
Mean values show a striking drop with each procedure for all 
fractions. However, the fact that this extends to HDL reduces 
the benefit of lowering total and LDL cholesterol. 11 
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Post-exchange Lipid Kinetics 
In the short term lipid concentrations are seen to rise 
and, whilst there may be some contribution from extravascular 
compartments, the preferred explanation is that this reflects 
secretion of newly made lipoprotein from the liver. Examined 
regularly these have returned to the pre-apheresis levels by 
day 14 (Figure VII). It follows that, to sustain maximally 
effective reductions, plasmaphereses should be carried-out at 
one rather than two week intervals. This recommendation 
assumes that more efficient clearance achieved with the 
intensive schedule will impact positively on cardiovascular 
disease but this remains an unproven contention. 
Nevertheless, even once every 14 days was sufficient to 
improve plasma levels over the commencing value but, after a 
three month period a stable plateau developed - as previously 
reported. 11 It is appreciated that this schedule reflects a 
pseudo-equilibrium and may not reach the concentration that is 
genetically governed. 
THE BLOOD COUNT 
Haemoglobin and Packed-cell Volume 
Both showed a statistically significant downward trend 
when plotted against time or number of exchanges. This was 
sharply reversed either by infusion of intravenous iron 
dextran or oral administration of 110 mg of ferrous gluconate 
three times a day. Conversely where neither intervention took 
place the steady deterioration continued (Figure VIII). 
Red Cell Indices 
A comparable response occurred in both mean cell volume 
















POST-EXCHANGE LIPID KINETICS 
2 4 6 8 10 
DAYS 
-Gv -+-AC -+-- YA --e- CF 
12 14 
Low density lipoprotein rose gradually and had returned to 
pre-treatment levels over a two week period. Similar patterns 
occurred with total cholesterol HDLC and triglycerides (data 










HAEMOGLOBIN AND PACKED-CELL VOLUME 
8L_ _______ __i__ _______ _.__ ______ ~ 
13 Jan 92 16 Feb 93 29 May 93 23 March 94 
Months 
-GV -+-AC --+- YA -e-- CF ~c, -+-JG 
The vertical axis shows haemoglobin in grams per decilitre: 
parallel data from PCV are not shown. Of the six patients 
those who received no iron had a continued drop in haemoglobin 
level. In contrast oral or parenteral replacement leads to 
prompt return to normal. 
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concentration (data not shown). 
ANALYSIS OF IRON INTAKE 
Hypochromic and microcytic erythropoiesis acquired during 
the observation period focused attention on the need to 
document adequacy of iron intake. It was demonstrated, 
probably as a result of the low-fat diet being ingested, that 
absolute quantities of iron were below the recommended daily 
allowance except in one patient (Figure IX). Since the latter 
measurements are generated for a normal population it follows 
that they are not strictly applicable to anaemic patients. 
Apart from the patients taking in less red meat than the 
remainder of the family the composition was qualitatively 
normal with neither increase or decrease in currently 
recognised promoters or inhibitors such as tannates, phytates 
or phosphates being present. 
EXCLUSION OF BLOOD LOSS 
Conversely collection of routine blood samples, even when 
corrected to the average anaemic haemoglobin level of these 
patients, accounted for a minimum loss of 1 7 mg per month. 
Over long periods of time no gastrointestinal or genitourinary 
tract symptoms or signs occurred. Patients young age and 
natural reticence precluded direct measurements on the stools. 
NUTRITIONAL STATUS 
Iron 
Gradual depletion of body iron stores was reflected in 
falling serum levels of this trace metal accompanied by rising 
total transferrin so that percentage saturation (data not 
shown) of the latter iron-transporting protein dropped 













These intakes, shown in mg/24 hours on the vertical axis, are 
without iron supplementation and, with a single exception, all 
study patients are seen to take in less iron than their 
recommended daily allowance: this reflects the low-fat diet 
ingested by these individuals. It is acknowledged that RDA is 
generated for a normal population and therefore not directly 
applicable to patients with iron deficiency anaemia. 
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found with mean serum ferritin dropping from 28 to 10 ng/mL. 
Theoretically these iron-binding proteins might be spuriously 
depressed from losses in the exchange procedure but this 
possibility was not specifically documented. In addition, 
depletion of transferrin could not be predicted from 
determining the albumin level, since the latter was supplied 
in the exchange fluid. Nevertheless the changes in these iron 
containing proteins correlated with the appearance of 
hypochromasia and microcytosis and appeared to be related to 
the development of iron deficiency. These abnormalities 
reversed promptly with replacement therapy. 
Vitamin B12 and Folate 
Neither of these essential haematinics varied at any 
stage during the study. 
SCREENING TESTS FOR HAEMOLYSIS 
Recognising that major nutrients for blood formation were 
approximately balanced, albeit iron only marginally in terms 
of sub-optimal quantitative intake, its additional loss 
possibly due to intravascular haemolysis, was examined. Here 
a significant trend for increase in lactic dehydrogenase was 
noted although red cell isoforms were not specifically raised 
(Figure X). It is noteworthy that total changes in this enzyme 
attributable to the procedure could be accounted for by its 
appearance in the discard fluid: additionally there was no 
selective depletion of one or other component. Concurrently 
haptoglobin was shown to be below or at the lower limit of 
normal again consistent with a mild degree of erythrocyte 













TOTAL LACTIC DEHYDROGENASE 
100 L__ _____ _L _______ J..__ _____ ~ 
13 Jan 92 16 Feb 93 27 May 93 4 Sep 93 
-GV -t-AC -*-YA -a- CF --*- Cl ~JG 
A gradual rise in the pre-exchange value is seen over time. 
This is interpreted as being due to haemolysis but red cell 
isoform did not specifically increase. As far as is known the 
assay method did not change during the study period. In the 
presence of normal folate balance and a raised reticulocyte 















~ Normal Range 
CF Cl JG 
C::::J Patients 
Appreciating that plasma exchange would acutely reduce 
haptoglobin levels, these were carried-out immediately before 
each procedure when steady state would have been re-
established. In the six individuals there was, on average, 
marginal reduction which is consistent with ongoing, albeit 
low-level, shortening in red cell survival. Since post-
exchange measurements were not carried-out comments about 
short-term rebound are not possible. The low level in JG, who 
had a porto-caval shunt, is noted but no further specific 
-
studies were undertaken to explore the impact on haptoglobi? 
or red cell kinetics. 
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RADIONUCLIDE INVESTIGATIONS 
in homozygotes not yet on plasma 
life-span was reduced. This 
It is noteworthy that, 
exchange, mean red cell 
establishes, for the first time, that haemolysis was 
associated with the disease itself. 
Of particular note is that the impaired survival did not 
correlate with iron deficiency. Specifically ferritin levels 
were normal in the three patients prior to exchange and two of 
the three additionally had normal percentage saturation of 
transferrin. This observation supports the contention that the 
association with hypercholesterolaemia rather than iron 
deficiency, with or without anaemia, underlies the reduced 
mean red cell life-span. Interestingly, when the same data 
were analysed using different mathematical models, the curves 
were roughly similar but, in keeping with international 
practice, data are presented using the weighted-mean method 
(Table 6) In one patient where there was an opportunity to 
compare life-span before and after apheresis no further 
decrement was demonstrated. 
In an alternative approach used to examine survival, loss 
of radiochromium in the urine gave equivocal results due to 
unreliable 24 hour collections (data therefore not shown). 
ERYTHROPOIETIC RESPONSE 
Reticulocytes 
Compared to 64 controls the homozygous individuals had a 
consistently normal percentage. However, within this 
population, there was a marginal shift from low through medium 
to high fluorescent cells. As a result the maturation index 
was elevated which implies that subtly younger erythrocyte.s 
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TABLE 6 
DEMOGRAPHIC DATA, IRON BALANCE AND RED CELL SURVIVAL 
Iron Loss 
T50Cr 
Mean Red % Saturation Ferritin Age Cell Patient 
Gender %RDA Discard In
 
(days) Lifespan 
of ( µg/L) (years) Bag Urine Transfenin Initials (mg) (mg) (days) 
GvdM 32 M 91 7 1.5 30.4 106
.7 6 16 
AC 24 F 47 4 2.05 24.2 
73.7 16 15 
YA 19 F 35 2.5 3.5 27.9 82.6
 13 12 
CF 19 M 152 8 3.4 31.0 1
11.8 14 7 
Cl 13 M 56 4 1.9 22.3 5
4.7 15 26 
I-
JG 23 F 35 2.5 0.18 ND 
ND ND ND 
TD 13 F 74 - - 22.0 53.6 8 89 
RI 25 F ND - - 26.0 72.2 22 60 
ES 24 F ND - - 24.1 71.7 36 22 
Ref era nee 100 0 0.03 25-32 90-150 20-40 20-250 
Range 
Iron intake shows reduced supply but absolute absorptio
n, 
necessary for calculating balance, was not determined. L
oss 
was measured by ICP-AES. In the discard plasma this is giv
en 
for a two week period that includes a single representati
ve 
apheresis. Urinary excretion for each exchange adds a furth
er 
loss ranging from O .18 to 3. 5 mg. These calculations do n
ot 
take into account additional minimum of 17 mg iron lost ea
ch 
month from diagnostic blood sampling. 
The first six patients are those studied whilst standardis
ed 
on the therapeutic plasmapheresis programme. Numbers 7, 8 
and 




are being released by a marrow responding to the reduced red 
cell mass (Figure XII). 
Collateral evidence for this statement, although weak, 
is found in the higher levels of pyruvate kinase and glucose-
6-phosphate dehydrogenase when compared to physiological 
values (Figure XIII) 
Additionally, in this context, was the plasma 
erythropoietin levels. In the first patient (AC) a blunted 
response was noted. However, with accumulation of further 
curves the observed to predicted (0/P) ratios were found to 
scatter widely about the mean normal value. This implies that 
enzyme output is appropriate and consistent with a intact 
functioning erythron (Figure XIV). 
EKTACYTOMETRY 
The need to examine integrity of the membrane was 
predicated on finding a shortened red cell survival before 
exchanges commenced and this was associated with an increased 
erythropoietin output which was 
appropriate. Additionally this 
anticipated reticulocyte output 
nevertheless physiologically 
hormonal drive elicited the 
in keeping with an intact 
response from the erythron. It is notable that, after repeated 
procedures, iron depletion occurred thereby raising the 
question of a causative mechanism. Arguing from previous 




haemoglobinuria, where low-grade intravascular 
























ft:;;;@3 Normal Range c=l Patients 
Al though the total number are within the normal range the 
slightly elevated maturation index is consistent with a 
marginally younger, and therefore more brightly fluorescing 










PYRUVATE KINASE AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE 
0 
GV AC YA CF Cl JG TD 






GV AC YA CF Cl JG TD 
~ Normal Range CJ Patients 
Both these red cell enzyme levels are in the upper normal 
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The top graph defines normal erythropoietin to haemoglobin ratio. 
The lower curves serially show over the two years of study 
(horizontal axis in weeks) the 0/P ratio for the prevailing 
haemoglobin level. Although one patient (AC) has a blunted response 
the pattern for the total group scatters around the mean. This is 
consistent with an appropriate output for the degree of anaemia. 
Each of the six patients on the plasma exchange programme were 
studied on at least five separate occasions and a normal 
control included in the run . In patients and controls the mean 
and standard deviation for whole cell deformabili ty (n=42) 
was 123.6 (12.4) and 130.9 (15.1); the corresponding figures 
for deformability of isolated membranes (n=27) was 148.7 
(30.6) and 153.21 (30.1); and for membrane fragmentation 
(n=27) was 84.1 (31.6) and 79.3 (31.6). These consistent 
trends fall just short of statistical significance. 
In recognition of the fact that considerable machine 
variation occurs and that similar findings happen 
independently of the lipid abnormality but in the presence of 
iron deficiency oral supplementation was given over a six week 
period and all the individuals restudied on one single day. 
Fortuitously, due to variable compliance only some of the 
patients fully corrected their stores as reflected in plasma 
ferritin levels. Notwithstanding this the two groups again 
showed uniformly impaired whole-cell and membrane 
deformability and increased fragmentation of ghosts that was 
not affected by iron status. This observation suggests that 
the ektacytometric defect may be attributable to the 
hypercholesterolaemic state and not necessarily a function of 
the iron deficiency. It is acknowledged that the numbers and 
the differences are small . Furthermore, the confounding effect 
of a portacaval-shunt in two patients cannot be resolved on 
the available data: nevertheless, these findings are 
consistent with an intrinsically defective erythrocyte 




Name Ferritin Patient 
ug/L 
GV 14 81 
YA 11 86 
JG 9 75 





Name Ferritin Patient 
ug/L 
AC 36 76 
CF 35 83 
CI 41 92 
PV 58 79 







Control Patient Control 
85 102 115 
95 95 90 
86 99 104 
84 98 98 
87.5 98.5 101.75 
DEFORMABILITY 
Cell Membrane 
Control Patient Control 
77 91 110 
80 95 107 
87 98 96 
77 102 110 
94 108 106 


















The lower limit of normal serum ferritin levels is 20ug/L. The 
crude data are presented as an osmoscan for whole cells and 
deformability and fragmentation scans respectively in the case 
of ghost membranes.105,107 
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IRON EXCRETION 
To link these observations it was 
demonstrate the route by which this element was 
necessary to 
being lost. 
Calorimetric techniques as used for serum determination 
fluctuated considerably when applied to the exchange fluid and 
urine so that the small amounts could not be reliably 
quantitated. Furthermore, ferritin could be demonstrated 
immunologically but its origin could not be attributed, with 
certainty, to red cells. 
The only way out of the dilemma seemed to be direct 
measurement using inductively coupled plasma-atomic emission 
spectroscopy: this was then applied to examine exchange fluid 
and urine samples collected around the time of the procedure. 
Two relevant facts emerged. Firstly, milligram quantities 
of iron were lost in each discard bag (Figure XV). 
Unfortunately it was not possible to identify the source or to 
correlate it with body stores prevailing at the time of the 
procedure. Secondly, a further significant excretory peak 
occurred in the post-apheresis urine. The latter seems to be 
related to the infusion of citrate used as anticoagulant that 
















IC CA VDM FC OT AY GJ 
Patient 
- 1st Exchange ~ 2nd Exchange c=J 3rd Exchange 
Inductively coupled plasma-atomic emission spectroscopy for 
the patients showed varying iron loss with each of three 
representative exchanges. This ranged from a high of 12 mg 





Plasma levels dropped dramatically after each run but had 
returned to normal within 14 days. Of note is a gradual 
elevation in whole blood value during the two years of study 
but this presently remains unexplained. 
LEUCOCYTES 
Neutrophils 
There was a gradual upward trend in the count although 
the differential spread did not change. This remains 
unexplained since it was not associated with any consistent 
alteration in the procedure and no correlation was found with 
any of the other variables. 
Function studies did not differ from controls and neither 
were influenced by apheresis. 
Lymphocytes 
Absolute numbers decreased as a result of the serial 
exchanges and this was demonstrably due to loss of the CD4 
helper-T sub-set (Figure XVI). 
Monocytes 
Apart from a reduction after the individual runs there 
was rapid reconstitution and, 
consistent effects. 
in the longer term, no 
THROMBOCYTOPOIESIS AND PLATELET FUNCTION 
Quantitative 
There was a drop in count after each exchange which 
corrected itself (Figure XVII) However with repeated 








GV AC YA CF Cl 
~ Normal Range c=J Initial c=J Final 
JG 
The percentage (vertical axis) pan-T cell markers did not 
change but there was a reduction over the two year period in 
the CD 4 population. This is consistent with the previously 
reported observation arising in the closely allied procedure 
of plateletapheresis. 23 
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FIGURE XVII 















GV AC YA CF Cl 
~PRE CJ POST 
Mean! SD (n • 24) 
The reduction consistently seen corrected within 48
 hours. In 
no instance was this sustained or associated with 
thrombocytopenic bleeding. The vertical axis is plat
elet count 
xl0 9 /L. 
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reaction to the gradual development of iron deficiency that 
paralleled the fall in haemoglobin (Figure XVIII). 
Qualitative 
No difference in aggregometry could be attributed to 
plasmapheresis when patients were compared to controls using 
various agonists. Paradoxically, and appreciating the small 
numbers of studies as well as the variability and technique, 
it is notable that homozygous individuals, although starting 
off apparently less aggregatable than normals studied at the 
same time, have an increased in vitro response to these agents 
after completion of the plasma exchange (Table 8). 
COAGULATION PROTEINS AND COMPLEMENT 
At the time of the apheresis there was a significant 
decrease in the proteins with prompt correction as previously 
reported. 1 
BIOCHEMISTRY 
Measurements of urea, creatinine, electrolytes, calcium 
and liver enzymes were not affected. Ionizable calcium is 
known to fall but, because replacement was routinely given, 
it never dropped below the normal range. 
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FIGURE XVIII 
DEVELOPMENT OF THROMBOCYTOSIS 
100L__~~~~~~~~~~~~~~~~~~~~~--' 
13 Jan 92 23 Mar 94 
-GV -+-AC ~YA -B-CF -x- Cl --+- JG 
With repeated procedures there was a mild increase in this 
measurement shown as platelet count 10 9 /L on the vertical 





Pre Post Pre I Post 
Adenosine diphosphate Ristocetin 
5 µm 1.5 µm 
PATIENT 50 (40-71) 50(40-80) 75(68-78) 78(56-84) 
CONTROL 73(52-85) 69(50-84) 86(78-95) 93(78-95) 
Adenosine diphosphate Adrenalin 
10 µm 10 µm 
PATIENT 65(52-79) 56(46-68) 54(13-79) 19(10-79) 
CONTROL 83(73-89) 81(79-89) 83 (75-90) 83(76-90) 
Adenosine diphosphate Collagen 
100 µm 15 µm 
PATIENT 73(63-79) 76(65-79) 66(60-69) 66(38-78) 
CONTROL 80(79-89) 77(71-89) 75(63-88) 73 (63-88) 
ADP ADP ADP RISTO ADR COLL 
5 µm 10 µm 100 µm 1.5 µm 10 µm 15 µm 
AC + + + - 0 + 
CF + + + - + 0 
CI + + + + + 
JG + + + + + + 
YA + + - - + -
In these studies the difference between pre- and post-
exchange to a variety of agonists was compared (upper box). A 
plus sign shows that the difference for the patient was bigger 
than the difference for the control: a negative sign shows the 
opposite (lower box). 
ADP = Adenosine diphosphate. 
ADR = Adrenalin. 






cardiovascular ravages of severe 
hypercholesterolaemia are reflected in the high morbidity and 
mortality among Afrikaners of Sub-saharan Africa where a 
founder effect for these genes is clearly documented. 7 - 9 The 
clinical presentation of homozygous patients has been 
abundantly described with the disfiguring xanthomata, 
thickened tendons and intimal lipid deposits in the cerebral 
and coronary circulation causing stroke and premature 
myocardial-infarction with death at an early age. 
Over the years attempts have been made to influence the 
relentless downhill course that these individuals follow. In 
heterozygotes dietary manipulation and lipid lowering agents 
are of some benefit but these turn out to be largely 
ineffective when profound low-density lipoprotein receptor 
dysfunction has been genetically transmitted as in the 
homozygote. Even extreme measures, including porto-caval 
anastomosis, have inconsistent and often little impact on 
survival. 
Given the ominous outlook associated with this 
hyperlipidaemic phenotype it was to be anticipated that 
attempts to interfere with metabolism by use of HMG-CoA 
reductase inhibitors would be made, particularly in 
combination with a variety of apheresis procedures. 10,ll 
While the different techniques for removing the offending 
cholesterol fractions continue to be intensively investigated, 
the ease and relatively low cost of centrifugal separation hap 
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established it as the cornerstone for chronic lipid-depleting 
approaches. With careful attention to procedural detail, their 
safety over many thousands of apheresis on a world-wide basis 
has been extensively confirmed. The short-term complications 
are well documented. By way of contrast the anaemia that 
develops in the course of repetitive schedules has received 
scant attention. One or two reports have briefly noted its 
occurrence and then dismissed the finding as simply responding 
to iron but without apparently considering its pathogenesis or 
potential clinical implication. 
It was for these reasons that a systematic investigation 
was undertaken to define incidence, characterise the 
haematologic lesion and then explore causation. 
The initial step was to establish that, at presentation, 
the blood count was normal. Indeed this was universally the 
case and it was only after many plasmaphereses that a falling 
haemoglobin was noted. At this time the red cells were 
hypochromic and 
both mean cell 
microcytic on examining 
haemoglobin and volume 
the stained smear: 
were reduced when 
directly determined using modern particle counters. 
Such acquired morphologic changes could best be explained 
by contraction and then absolute depletion of body iron 
stores. A number of mechanisms could theoretically be 
operating. In the first instance, dietary intake might be sub-
optimal as a result of ingesting a diet low in fat and 
cholesterol. This postulate was confirmed when detailed 
questionnaires were completed by all the patients in the 
cohort showing that, in the majority, supply only marginally 
met the daily recommended allowance needed for normal 
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erythropoiesis. Given these circumstances maximal extraction 
from food would be necessary to meet physiologic needs. It is 
therefore notable that, in the absence of any evidence for 
loss from the gastrointestinal or genitourinary tract, 
compensation was sufficient to sustain a normal haemoglobin 
level with erythropoiesis being normochromic and normocytic. 
Thus, where data were available at patient registration 
adequate stores were present as reflected in iron, transferrin 
as well as its percentage saturation and serum ferritin 
levels. 
This basal state was 
plasmaphereses leading to 
seeking to explain the 
seen 
the 
to be disrupted by repeated 
development of anaemia. In 
pathogenesis 
appreciated that substantial amounts of 
it was immediately 
iron were · lost in 
consequence of repeated blood sampling. Of rather greater 
interest was the previously unreported possibility that red 
cell breakdown might occur in the extracorporeal circuit and 
lead to low-grade intravascular haemolysis: here precedent 
exists in patients with paroxysmal nocturnal haemoglobinuria. 
That such a mechanism might be operative in these subjects 
gained support from such a dramatic event associated with 
apheresis in a patient undergoing blood-group change en route 
to bone marrow transplantation where cyclophosphamide 
conditioning was believed to have damaged erythrocytes 
sufficiently for them to lyse during the procedure. 6 
To explore the possibility of procedure-related 
haemolysis participants were screened using serum lactic 
dehydrogenase and haptoglobin levels. The former showed a 
gradual rise over long periods of time consistent with an 
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evolving haemolytic process. However no particular isoform was 
selectively elevated so that the origin of the enzyme could 
not be precisely defined. Furthermore, it might reasonably 
have been anticipated that significant red cell breakdown 
would characterise the first few treatments where the 
circulating population included older cells. Accordingly, once 
these had been removed, the incoming reticulocytes should have 
been less vulnerable to such mechanical injury. Thus, in the 
face of normal folate _values, the reason for the raised LDH 
remains unexplained. However it is speculated that the mild 
elevation of this enzyme may reflect iron depletion and 
impaired erythrocyte survival. Similarly plasma haptoglobin is 
at the lower limit of normal. This is again consistent with 
ongoing but low-level haemolysis. Such minimal depression may 
well reflect the relative resistance of younger cells 
circulating in the regularly exchanged individual. 
Recognising that these assays did not provide specific 
information direct determination of mean red cell life-span, 
using radionuclides, was undertaken. Here the significant 
shortening found is worthy of particular comment since this 
defect was present in three subjects not undergoing plasma 
exchange and could therefore be ascribed to an intrinsically 
defective erythrocyte. It was scientifically interesting that, 
irrespective of whichever model is used for curve fitting, all 
gave comparable results and are within the recommendations 
made for this purpose by the International Committee for 
Standardisation in Haematology. Attempts to cross-check these 
findings were made by determining radiochromium excretion in 
the urine. These measurements did not give consistent figures~ 
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explicable to a large extent by varying compliance with urine 
collection. The latter fact was evident when urinary 
creatinine levels were shown to be inappropriately low for 
body mass. 
Advantage was taken of the isotope methods to measure 
blood loss related to the exchange. No significant leak of 
radio-labelled cells was found. Of further note is the 
observation that, where plasma volumes were determined before 
and after each procedure these, as well as blood volumes, were 
found to be unaffected. Stated differently the attention to 
detail insured that each was isovolaemic and that patients 
were left in neither positive nor negative fluid balance. 
Taking all this data together it might reasonably be 
concluded that, prior to initiation of the apheresis protocol, 
a red cell defect already existed. Here slightly accelerated 
removal of the effete red cells by reticuloendothelial system 
was compensated for by simply accelerating erythropoiesis. In 
this context iron conservation is sufficient to maintain the 
otherwise precarious trace metal balance. 
Any disturbance to this fragile homeostatic balance 
raises three other considerations. 
Firstly, is the extent to which the erythron in these 
patients retains its capacity to respond to stress. That this 
is largely intact is supported by the finding of a compensated 
haemolytic state with a young erythroid population in the 
circulation as reflected in a reticulocyte maturation index 
consistent of their early release from the marrow compartment. 
Additionally, an enzyme pattern was found for glucose-6-
phosphate dehydrogenase and pyruvate kinase associated with 
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such a stimulated response. Whether these levels were dampened 
by the concurrently present iron deficiency anaemia 
restricting haemoglobin synthesis is possible but a point not 
tested in this study. Conversely it is not inconceivable that 
the relatively modest shortening of survival and marginally 
reduced plasma haptoglobin are a consequence of somewhat 
greater resistance of young cells to breakdown by shear 
stresses found under these circumstances. It can be speculated 
that bigger differences may have been evident had it been 
possible to make these measurements when commencing aphereses 
rather than when the older cohort of red cells had already 
been depleted as a result of the initial exchanges. 
Secondly and along the same lines, is the question as to 
why erythrocyte life-span is reduced particularly after 
sufficient time had elapsed for the older and more fragile 
members to have been removed. Again, with precedent from 
observations where lipid abnormalities give rise to impaired 
membrane integrity, the hypothesis was advanced that they 
were less deformable than normal. This would place them at 
continuing risk for damage during passage through the micro-
circulation and particularly in the hostile environment of the 
spleen. Support for this concept was obtained using 
ektacytometry which is a method well suited to reproducing, in 
the laboratory, conditions that are thought to exist in the 
capillaries. The use of this technique showed a clear but non-
significant trend for both this abnormality as well as an 
increased fragility. That statistical differences were not 
achieved may well reflect the small sample size that creates 
difficulty with obtaining a narrow standard deviation. It 
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would be proper to inject a note of caution into such an 
interpretation since further patients would need to be studied 
in order that this postulate can be more rigorously tested. 
No discussion of these two functional defects would be 
complete without recognising that iron deficiency, in its own 
right, may give rise to similar findings. Indeed the entity of 
paradoxical hyperviscosity was described in just this context. 
That such nutritional disturbances may have contributed to the 
shortened survival remains a possibility but is thought to be 
excluded by repeating the ektacytometric measurements, 
following iron repletion, and demonstrating that they did not 
differ from serial studies carried-out in the same cases 
whilst they were on apheresis. An additional point in this 
context is that the population at greatest risk for in vivo 
and in vitro breakdown are the older red cells: however the 
compensatory situation prevailing in these 
have diminished any influence of aged 
deformability, fragility and life-span. 
patients should 
erythrocytes on 
The third and final point was to uncover the link between 
commencement of aphereses, iron loss from the body leading to 
storage depletion and formation of intrinsically fragile 
cells. In the first instance repeated sampling during routine 
procedures, which increased when specific studies were being 
undertaken, placed a substantial strain on the quantity of 
t his trace element available for haemoglobin synthesis. In 
l ooking further afield the limitations of suitable methods 
became apparent. Thus one appreciated that colorimetric 
techniques, 
i nsensitive 
as applied to plasma 
and consequently 
and urine, were relatively 
failed to demonstrate 
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haemosiderin. Similarly the unreliability of attempting to 
extrapolate excretion of this trace metal to the presence of 
immunologic determination of ferritin in the discard fluid 
provided a conundrum. Was the element getting-out but in a 
form that escaped detection by these cruder methods? Using 
ICP-AES it was possible to unequivocally demonstrate that this 
was the case and, furthermore, this loss became significant 
when the marginal intake was considered. Thus milligram 
quantities were revealed to be present in the exchange fluid 
discarded with each run. In addition, there were peaks in the 
urinary iron concentration immediately following each 
exchange. This could best be explained by chelation of the 
free metal from the circulation in response to citrate used as 
the anticoagulant in the routine procedures. 
Under these circumstances the reduced amounts available 
from the diet are such that negative balance is present in 
some cases. In others any minor additional loss from normal 
menstruation or repeated blood sampling carried-out during the 
course of their management is probably sufficient to tip the 
scales in this adverse direction. 
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CHAPTER X 
SUMMARY AND CONCLUSIONS 
Patients with homozygous familial h
ypercholesterolaemia 
on long-term plasmapheresis programme
s have occasionally been 
noted to have an iron-responsive anae
mia. To date no attempt 
has apparently been made to define i
ts incidence or explore 
pathophysiology. Accordingly this the
sis reports the universal 
occurrence of a falling haemoglob
in level in all these 
individuals and its systematic stud
y, in four consecutive 
phases, over a two year period. 
The first of these documented that, 
wherever data was 
available at registration, haematolog
ic and iron values were 
normal but, in the course of serial 
plasmapheresis, there is 
the predictable development of hyp
ochromic and microcytic 
erythropoiesis. 
In the second, after iron loss from g
astrointestinal and 
genitourinary tract had been exclude
d, availability of this 
haematinic from the low fat diet 
routinely ingested was 
examined by questionnaire and found 
only marginally adequate 
to meet minimal daily requirements fo
r normals and therefore 
likely to be insufficient should de
mands increase for any 
reason. One such drain on availabl
e stores would be loss 
through repeated blood sampling needed
 to ensure safety of the 
procedures and this might well become 
more acute at times when 
research protocols necessitated ad
ditional collections. A 
further mechanism might be the occurr
ence of haemosiderinuria 
due to low-grade intravascular ha
emolysis as occurs so 
distinctively in paroxysmal noctu
rnal haemoglobinuria. 
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Suggestive evidence for this type of pathway to be operative 
was found in the minimally reduced haptoglobin and raised 
serum lactic dehydrogenase levels. Haematologically this 
postulate was supported by the presence of a young red cell 
population reflected in a subtly raised reticulocyte 
maturation index, coupled with glucose-6-phosphate 
dehydrogenase and pyruvate kinase levels at the upper limit of 
normal. Shortened erythrocyte survival was proven to be 
present, using radiochromium red cell labelling prior to 
either creation of an arteriovenous fistula or commencing the 
apheresis protocol. Such a lesion has not previously been 
described. At the same time erythropoietin levels were 
appropriate for the degree of anaemia supporting an intact 
bone marrow response. These observations are consistent with 
there being an enhancement of the normal extravascular route 
for removal of effete cells by the reticuloendothelial system 
which is, in effect, an iron-conserving process. 
A third phase was designed to explore the impact of 
plasma exchange on disturbing this fragile homeostatic balance 
arguing that the cells may be intrinsically abnormal as a 
consequence of the hypercholesterolaemic environment in which 
they circulate. Ektacytometry was employed to demonstrate 
reduced deformability of the intact cells: this presumably 
resided in the membrane since the lesion persisted when 
erythroid ghosts were studied. Additionally isolated membranes 
showed increased fragility. This combination of the two 
defects might reasonably be interpreted as predisposing 
erythrocytes to accelerated mechanical breakdown either in the 
extracorporeal circuit or, once returned to the body, within 
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the micro-circulation perhaps particularly in the spleen. Such 
mechanisms, active over long periods of time, could aggravate 
the negative iron balance. 
In the fourth and final series of experiments the loss of 
this trace metal to the external environment was explored. 
Standard colorimetric methods gave equivocal results probably 
due to their lack of sensitivity. Ferritin could be recovered 
from the exchange fluid but methodology was not available to 
determine its origin. Conversely the use of ICP-AES showed 
milligram losses in the discard fluid with each exchange and, 
concurrently, peaks of urinary excretion at the time of each 
procedure. This additional drainage on already compromised 
stores could not be compensated for by the sub-optimal intake 
from the diet so that an impaired delivery 
rate limiting for red cell formation. 
to plasma became 
Relevantly iron 
deficiency, in 
cause for the 
its own right, was excluded as the dominant 
ektacytometrically demonstrated lesions and, 
presumably therefore, the shortened erythrocyte survival. 
It is concluded, from the data presented, that the 
development of hypochromic and microcytic anaemia evolves as a 
consequence of serial plasmaphereses in these individuals and 
does so through a number of inter-related factors. One is 
inadequate iron intake. A second is blood loss through 
repeated sample collections. Thirdly, and perhaps 
scientifically the most interesting, is superimposition of 
loss in the exchange fluid at the time of plasmapheresis when 
intrinsically fragile red cells undergo accelerated breakdown. 
Two final comments are appropriate. 
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Firstly this appears to be the initial report of such a 
haematologic defect in the homozygous patients. Secondly, the 
study has direct clinical relevance. Thus the simple expedient 
of supplementation will prevent symptoms attributable both to 
falling haemoglobin and any superimposed paradoxical 
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